Core Laboratories NV Net Income
| CLB Stock | USD 19.59 0.05 0.26% |
As of the 2nd of February, Core Laboratories shows the Mean Deviation of 1.97, risk adjusted performance of 0.1126, and Downside Deviation of 2.55. Core Laboratories technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Core Laboratories' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Core Laboratories' valuation are provided below:Core Laboratories NV does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. Projected growth potential of Core fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Core Laboratories assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Core Laboratories' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Core Laboratories should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Core Laboratories' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Core Laboratories 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Core Laboratories' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Core Laboratories.
| 11/04/2025 |
| 02/02/2026 |
If you would invest 0.00 in Core Laboratories on November 4, 2025 and sell it all today you would earn a total of 0.00 from holding Core Laboratories NV or generate 0.0% return on investment in Core Laboratories over 90 days. Core Laboratories is related to or competes with Crossamerica Partners, Borr Drilling, Precision Drilling, Granite Ridge, Nabors Industries, Vitesse Energy, and MorningStar Partners. Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and ga... More
Core Laboratories Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Core Laboratories' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Core Laboratories NV upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.55 | |||
| Information Ratio | 0.1229 | |||
| Maximum Drawdown | 11.7 | |||
| Value At Risk | (4.32) | |||
| Potential Upside | 5.51 |
Core Laboratories Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Core Laboratories' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Core Laboratories' standard deviation. In reality, there are many statistical measures that can use Core Laboratories historical prices to predict the future Core Laboratories' volatility.| Risk Adjusted Performance | 0.1126 | |||
| Jensen Alpha | 0.2947 | |||
| Total Risk Alpha | 0.2078 | |||
| Sortino Ratio | 0.1291 | |||
| Treynor Ratio | 0.2133 |
Core Laboratories February 2, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1126 | |||
| Market Risk Adjusted Performance | 0.2233 | |||
| Mean Deviation | 1.97 | |||
| Semi Deviation | 2.24 | |||
| Downside Deviation | 2.55 | |||
| Coefficient Of Variation | 696.14 | |||
| Standard Deviation | 2.68 | |||
| Variance | 7.19 | |||
| Information Ratio | 0.1229 | |||
| Jensen Alpha | 0.2947 | |||
| Total Risk Alpha | 0.2078 | |||
| Sortino Ratio | 0.1291 | |||
| Treynor Ratio | 0.2133 | |||
| Maximum Drawdown | 11.7 | |||
| Value At Risk | (4.32) | |||
| Potential Upside | 5.51 | |||
| Downside Variance | 6.51 | |||
| Semi Variance | 5.03 | |||
| Expected Short fall | (2.12) | |||
| Skewness | 0.117 | |||
| Kurtosis | 0.6528 |
Core Laboratories Backtested Returns
Core Laboratories appears to be not too volatile, given 3 months investment horizon. Core Laboratories secures Sharpe Ratio (or Efficiency) of 0.14, which signifies that the company had a 0.14 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Core Laboratories NV, which you can use to evaluate the volatility of the firm. Please makes use of Core Laboratories' Downside Deviation of 2.55, mean deviation of 1.97, and Risk Adjusted Performance of 0.1126 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Core Laboratories holds a performance score of 11. The firm shows a Beta (market volatility) of 1.76, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Core Laboratories will likely underperform. Please check Core Laboratories' value at risk, expected short fall, and the relationship between the treynor ratio and downside variance , to make a quick decision on whether Core Laboratories' price patterns will revert.
Auto-correlation | 0.29 |
Poor predictability
Core Laboratories NV has poor predictability. Overlapping area represents the amount of predictability between Core Laboratories time series from 4th of November 2025 to 19th of December 2025 and 19th of December 2025 to 2nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Core Laboratories price movement. The serial correlation of 0.29 indicates that nearly 29.0% of current Core Laboratories price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.29 | |
| Spearman Rank Test | 0.38 | |
| Residual Average | 0.0 | |
| Price Variance | 1.77 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Core Laboratories NV reported net income of 32.15 M. This is 98.58% lower than that of the Energy Equipment & Services sector and 31.41% lower than that of the Energy industry. The net income for all United States stocks is 94.37% higher than that of the company.
Core Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Core Laboratories' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Core Laboratories could also be used in its relative valuation, which is a method of valuing Core Laboratories by comparing valuation metrics of similar companies.Core Laboratories is currently under evaluation in net income category among its peers.
Core Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0497 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 1.06 B | |||
| Shares Outstanding | 46.56 M | |||
| Shares Owned By Insiders | 1.24 % | |||
| Shares Owned By Institutions | 98.76 % | |||
| Number Of Shares Shorted | 4.03 M | |||
| Price To Earning | 101.74 X | |||
| Price To Book | 3.37 X | |||
| Price To Sales | 1.77 X | |||
| Revenue | 523.85 M | |||
| Gross Profit | 103.23 M | |||
| EBITDA | 73.27 M | |||
| Net Income | 32.15 M | |||
| Cash And Equivalents | 19.16 M | |||
| Cash Per Share | 0.29 X | |||
| Total Debt | 180.14 M | |||
| Debt To Equity | 1.29 % | |||
| Current Ratio | 2.23 X | |||
| Book Value Per Share | 5.89 X | |||
| Cash Flow From Operations | 56.39 M | |||
| Short Ratio | 11.02 X | |||
| Earnings Per Share | 0.68 X | |||
| Price To Earnings To Growth | 1.67 X | |||
| Target Price | 15.83 | |||
| Number Of Employees | 3.3 K | |||
| Beta | 1.04 | |||
| Market Capitalization | 916.31 M | |||
| Total Asset | 590.41 M | |||
| Retained Earnings | 150.28 M | |||
| Working Capital | 129.02 M | |||
| Current Asset | 238.55 M | |||
| Current Liabilities | 120.76 M | |||
| Annual Yield | 0 % | |||
| Five Year Return | 2.66 % | |||
| Net Asset | 590.41 M | |||
| Last Dividend Paid | 0.04 |
About Core Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Core Laboratories NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Core Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Core Laboratories NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:Check out You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. Projected growth potential of Core fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Core Laboratories assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Core Laboratories' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Core Laboratories should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Core Laboratories' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.